SRF (G93) Antibody

Current Country :

Download PDF Datasheet

Catalogue No : BS1332

Alternative Name for SRF (G93) Antibody
Host   Reactivity Size Application stock price cart
BS1332 H,M,R 100μg WB IHC 238.00
Contact information

Email:shdiahds@163.com
Phone:+1-909-839-7620
Fax:+1-909-839-7620

Click here for qusetions for this product!

Product

1 mg/ml in Phosphate buffered saline (PBS) with 15 mM sodium azide, approx. pH 7.2.

Purification & Purity

The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen and the purity is > 95% (by SDS-PAGE).

Specificity

SRF (G93) antibody detects endogenous levels of SRF protein.

Applications (Recommended Dilutions)

WB: 1:500~1:1000 IHC: 1:50~1:200

Western Blot(WB)

Western blot (WB) analysis of SRF (G93) antibody in extracts from NIH/3T3 cells treated witn PMA 125ng/ml 30' cells.

Immunohistochemistry (IHC)

Immunohistochemistry (IHC) analyzes of SRF (G93) antibody in paraffin-embedded human breast carcinoma tissue.

Storage&Stability

Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze-thaw cycles.

Background

Serum response factor (SRF) is a transcription factor that binds the serum response element (SRE), a sequence that mediates the transient response of many cellular genes to growth stimulation. SRF-binding sites are also constitutive promotor elements in many muscle-specific promotors. At the c-Fos SRE, formation of a ternary complex containing SRF and its accessory protein p62TCF appears to be important for signal transduction. Two related Ets domain proteins, Elk-1 and SRF accessory protein-1 (SAP-1) have DNA binding properties identical to that of p62TCF. Elk-1 and SAP-1 contain two homologous regions of which the two amino-terminal regions, the Ets domain (box A) and the B box, mediate ternary complex formation with SRF. The third homologous region, the C box located toward the C-terminus of the proteins, contains conserved consensus phosphorylation sites for MAP kinases.